AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $683,000 | -8.4% | 42,662 | +2.2% | 0.00% | 0.0% |
| Q1 2021 | $746,000 | +35.9% | 41,748 | +2.8% | 0.00% | 0.0% |
| Q4 2020 | $549,000 | +14.9% | 40,622 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $478,000 | -23.3% | 40,653 | -3.8% | 0.00% | 0.0% |
| Q2 2020 | $623,000 | +9.9% | 42,240 | +0.5% | 0.00% | 0.0% |
| Q1 2020 | $567,000 | -32.3% | 42,025 | +21.3% | 0.00% | 0.0% |
| Q4 2019 | $837,000 | -13.4% | 34,636 | -31.2% | 0.00% | 0.0% |
| Q3 2019 | $967,000 | -34.9% | 50,317 | +0.1% | 0.00% | -50.0% |
| Q2 2019 | $1,486,000 | +40.6% | 50,278 | +192.7% | 0.00% | 0.0% |
| Q3 2018 | $1,057,000 | -38.8% | 17,175 | -32.8% | 0.00% | -33.3% |
| Q2 2018 | $1,728,000 | +25.1% | 25,574 | +0.5% | 0.00% | +50.0% |
| Q1 2018 | $1,381,000 | -59.4% | 25,454 | -55.3% | 0.00% | -66.7% |
| Q4 2017 | $3,399,000 | +19.3% | 56,894 | -3.0% | 0.01% | 0.0% |
| Q3 2017 | $2,850,000 | -6.2% | 58,633 | +1.4% | 0.01% | -14.3% |
| Q2 2017 | $3,040,000 | -18.7% | 57,841 | -29.8% | 0.01% | -22.2% |
| Q1 2017 | $3,737,000 | -14.1% | 82,393 | -39.8% | 0.01% | -18.2% |
| Q4 2016 | $4,352,000 | -3.6% | 136,832 | -2.8% | 0.01% | -8.3% |
| Q3 2016 | $4,515,000 | +388.1% | 140,729 | +167.7% | 0.01% | +300.0% |
| Q2 2016 | $925,000 | +54.7% | 52,563 | +6.9% | 0.00% | +50.0% |
| Q1 2016 | $598,000 | -53.8% | 49,152 | -7.5% | 0.00% | -60.0% |
| Q4 2015 | $1,294,000 | +27.5% | 53,139 | -7.1% | 0.01% | +25.0% |
| Q3 2015 | $1,015,000 | -37.6% | 57,196 | -37.9% | 0.00% | -33.3% |
| Q2 2015 | $1,626,000 | -3.8% | 92,130 | +70.8% | 0.01% | -14.3% |
| Q1 2015 | $1,690,000 | +581.5% | 53,931 | +349.4% | 0.01% | +600.0% |
| Q3 2014 | $248,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |